Blog

Blog sidebar
18 May 2021

OSTEOARTHRITIS: CURRENT SITUATION

Musculoskeletal disorders represent the fourth cause of disability following neuropsychiatric disorders, cancers and cardiovascular diseases in both developed and developing countries. These injuries include a variety of disorders that cause pain in bones, joints, muscles, and surrounding structures. Osteoarthritis (OA) is considered as the most common of the articular disorders and is frequently cited as [...]
11 May 2021

BIO US 2021

One month remaining before digital BIO US 2021! On June 14-18, Yassine will attend BIO International Convention Digital 2021. He will be pleased to evaluate whether the in vivo services offered by ANS Biotech can be helpful for your research projects. Without further delay, join him to the event!

14 Apr 2021

FOCUS ON OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY: MECHANISMS AND PHARMACOLOGY

For this first blog, Laurent DIOP, Chief Scientific Officer at ANS Biotech, would like to focus on Neuropathic Pain and more specifically on Chemotherapy-induced peripheral neuropathy (CIPN). Since its creation in 2006, ANS Biotech is fully involved in this thematic and daily serves its Clients, all around the world, using relevant in vivo models for [...]
30 Mar 2021

NEW ALGOGram™ SESSION

The registration for the upcoming ALGOGram™ session is now open! A decision-making guide to accelerate your Pain programs.

18 Mar 2021

BIOEUROPE SPRING – LAST CALL!

Last chance to schedule an e-meeting with Julie and Yassine directly on the platform of the event : https://informaconnect.com/bioeurope-spring/ ! They look forward to discussing with you about your Pain project and the possibility to start a great and promising collaboration!

16 Mar 2021

A growing team!

New arrivals, new positions: who are they? Whithin the last 6 months, 3 new people have been hired and 3 people have moved towards new responsabilities into the company. Discover below their profile! Yassine Darbaky Chief Business Officer Violette Maffre Head of Operational Production Julie Chamalet Business Development Assistant After 13 years spent as Head [...]
22 Feb 2021

BIOEUROPE SPRING

Without further delay, join Julie and Yassine to the event: https://informaconnect.com/bioeurope-spring/ and let’s schedule with them an e-meeting!

17 Feb 2021

NEUROPATHIC PAIN: WHERE ARE WE TODAY ?

Neuropathic pain refers to the pain caused by damage or disease affecting the somatosensory nervous system and symptomized by a hypersensitivity. Today, Neuropathic Pain is relatively common, afflicting 7% to 8% of the population around the world. Various treatments exist in this field, but what is the real current situation ? The Neuropathic Pain market [...]
26 Jan 2021

New ALGOGram™ session

The registration for the upcoming ALGOGramTM session is now open! A decision-making guide to accelerate your Pain programs.